Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Sep. 30, 2023 shares	Sep. 30, 2023 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Robert Zerbe [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On August 11, 2023, Robert Zerbe, Chairman of the Vericel Corporation Board of Directors, entered into a Rule 10b5-1 trading arrangement providing for the potential sale of up to 17,000 shares of our common stock between November 15, 2023, and August 30, 2024;
Name	Robert Zerbe
Title	Chairman of the Vericel Corporation Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 11, 2023
Arrangement Duration	289 days
Aggregate Available	17,000	17,000
Jonathan Hopper [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On August 17, 2023, Jonathan Hopper, Vericel Corporation’s Chief Medical Officer, entered into a Rule 10b5-1 trading arrangement providing for the potential sale of up to 15,000 shares of our common stock between November 20, 2023 and October 31, 2024;
Name	Jonathan Hopper
Title	Chief Medical Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 17, 2023
Arrangement Duration	346 days
Aggregate Available	15,000	15,000
Michael Halpin [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On August 31, 2023, Michael Halpin, Vericel Corporation’s Chief Operating Officer, entered into a Rule 10b5-1 trading arrangement providing for the potential sale of up to 32,834 shares of our common stock between November 30, 2023 and August 30, 2024;
Name	Michael Halpin
Title	Chief Operating Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 31, 2023
Arrangement Duration	274 days
Aggregate Available	32,834	32,834
Dominick Colangelo [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On September 1, 2023, Dominick Colangelo, Vericel Corporation’s President and Chief Executive Officer, entered into a Rule 10b5-1 trading arrangement providing for the potential sale of up to 431,849 shares of our common stock between December 6, 2023 and December 31, 2024; and
Name	Dominick Colangelo
Title	President and Chief Executive Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 1, 2023
Arrangement Duration	391 days
Aggregate Available	431,849	431,849
Jonathan Siegal [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On September 14, 2023, Jonathan Siegal, Vericel Corporation’s Principal Accounting Officer, entered into a 10b5-1 Plan providing for the potential sale of up to 23,800 shares of our common stock between December 13, 2023 and May 17, 2024.
Name	Jonathan Siegal
Title	Principal Accounting Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 14, 2023
Arrangement Duration	156 days
Aggregate Available	23,800	23,800